These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33745969)

  • 1. Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes.
    Johé P; Jaenicke E; Neuweiler H; Schirmeister T; Kersten C; Hellmich UA
    J Biol Chem; 2021; 296():100565. PubMed ID: 33745969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
    McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.
    Kerr ID; Wu P; Marion-Tsukamaki R; Mackey ZB; Brinen LS
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e701. PubMed ID: 20544024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.
    Nikolskaia OV; de A Lima AP; Kim YV; Lonsdale-Eccles JD; Fukuma T; Scharfstein J; Grab DJ
    J Clin Invest; 2006 Oct; 116(10):2739-47. PubMed ID: 16998589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Ettari R; Tamborini L; Angelo IC; Micale N; Pinto A; De Micheli C; Conti P
    J Med Chem; 2013 Jul; 56(14):5637-58. PubMed ID: 23611656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R
    ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei.
    Mackey ZB; O'Brien TC; Greenbaum DC; Blank RB; McKerrow JH
    J Biol Chem; 2004 Nov; 279(46):48426-33. PubMed ID: 15326171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; De Luca F; Bogacz M; Zimmer C; Wagner A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug combination studies of PS-1 and quercetin against rhodesain of
    Di Chio C; Previti S; De Luca F; Allegra A; Zappalà M; Ettari R
    Nat Prod Res; 2022 Aug; 36(16):4282-4286. PubMed ID: 34533390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the enzyme name 'rhodesain' be discontinued?
    Steverding D; Caffrey CR
    Mol Biochem Parasitol; 2021 Sep; 245():111395. PubMed ID: 34246720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
    Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
    Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R
    Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.
    Jung S; Fuchs N; Johe P; Wagner A; Diehl E; Yuliani T; Zimmer C; Barthels F; Zimmermann RA; Klein P; Waigel W; Meyr J; Opatz T; Tenzer S; Distler U; Räder HJ; Kersten C; Engels B; Hellmich UA; Klein J; Schirmeister T
    J Med Chem; 2021 Aug; 64(16):12322-12358. PubMed ID: 34378914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; Totaro N; De Luca F; Allegra A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug combination studies of curcumin and genistein against rhodesain of
    Ettari R; Previti S; Maiorana S; Allegra A; Schirmeister T; Grasso S; Zappalà M
    Nat Prod Res; 2019 Dec; 33(24):3577-3581. PubMed ID: 29897253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.
    Giroud M; Dietzel U; Anselm L; Banner D; Kuglstatter A; Benz J; Blanc JB; Gaufreteau D; Liu H; Lin X; Stich A; Kuhn B; Schuler F; Kaiser M; Brun R; Schirmeister T; Kisker C; Diederich F; Haap W
    J Med Chem; 2018 Apr; 61(8):3350-3369. PubMed ID: 29590750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.